News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This board, or just you? How is the identity of a family member relevant to what is being asked? You put the oof in GOOF! Provide any evidence that what is being questioned has any validity whatsoever and I’ll provide the identity.
Oof! This didn’t age well! Just curious as to what you know about this company that would make you post such a bold statement over and over? Seems manipulative to me.
But you still haven’t proved him wrong! 🤡
Yawn! And that’s why you’re still here holding is because the company has never followed through on anything! Next, you are specifically here waiting for TSOI to get shut down and this event will make your current TSOI holdings more prosperous! I can already hear you and Frank Sinatra doing a duet to the song “I Did It My Way”!!!
Yawn… come back when you can prove me wrong. Show me one thing this company has ever followed through on. You can’t do it! Keep responding with your nonsense because that’s all you can do. Lmao! Such clowns!
Can’t wait for the truth to come out! Only a matter of time. Anyone that still believes in this is an absolute fool. What has this company done or followed through on to prove the “bashers” wrong? Don’t you think if this company had anything to silence the negativity we would’ve seen it already? Come on folks, it’s about time you all see this for what it is. Everything this company does leaves people with more questions than answers. How’s that “ONGOING PHASE 3” working out for you bulls? Or anything else that kept you all dangling like puppets? And keep your stupid rebuttals to yourself if you can’t answer any questions in regards to anything that has been asked. You’re all pathetic and your failed attempts at luring newbies is quite laughable. Question my motives and reasons for sticking around all you want, but it doesn’t change the fact this company has followed through on ABSOLUTELY NOTHING!!!! 0.000 is a result of lies, not the people questioning those lies.
LetsCHere must be a keyboard warrior for this company. Do you wear a cheerleading skirt when you’re simping for this mess? 💋😆 You should change your name to LetsCHeer! 💋😆
That Ichim dude is getting his ass handed to him on ST. He whines like a little bitch. Funny to see all the minions come out and support him. They don’t even want him posting on other boards. 😆😆
Stopped in to see if anything was new .Same people still bashing a not quite penny stock . Sad life . Buy some blue chips guys you will sleep better.
💯 correct. I hope my sarcasm is easily detected in my posts. This is nothing but trash.
|
Followers
|
524
|
Posters
|
|
|
Posts (Today)
|
5
|
Posts (Total)
|
65778
|
|
Created
|
10/04/08
|
Type
|
Free
|
| Moderators BigBadWolf johnnytrader33 JMC$ Yooperman Hogwarts | |||
Preclinical Data Suggests QuadraMune™ Prevents Stress-Induced Suppression of Neurogenesis More Effectively than Prozac
OCEANSIDE, Calif., Dec. 9, 2020 /PRNewswire/ -- Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today new data suggesting the possibility that QuadraMune™ may mediate neuroprotective activity through preserving the ability of regenerative brain cells to proliferate subsequent to psychological stress.
The experiments, which involved exposing mice to established stressors, demonstrated that specific areas of the brain associated with production of new brain cells are damaged by stress. In agreement with previously published research, administration of fluoxetine (Prozac™) protected the brain from stress-induced damage. Surprisingly, QuadraMune™ administration appeared superior to Prozac™ at stimulating proliferation of new brain cells.
"QuadraMune™ which is currently in a clinical trial for prevention of COVD-191, has also been demonstrated to possess anti-inflammatory activity in other clinical trials, suppressing cytokines such as IL-62, which are known to be involved in depression3 and suicide4" said Kalina O'Connor, Director of Campbell Neurosciences and co-inventor on the patent. "Given major depressive disorder causes a significant risk for suicide, we are highly interested in exploring the use of QuadraMune™ for preventing suicide."
"Although much enthusiasm has been generated over the planned distribution of the COVID vaccine, at present little is being done to address mental health issues that are being exacerbated by the current pandemic" said Dr. James Veltmeyer, co-inventor of the patent, and Chief Medical Officer of the Company. "If current results are reproducible, the possibility that a nutraceutical would concurrently boost immunity while preserving mental health is highly enticing."
"It has not escaped us that COVID-19 is associated with increased inflammatory cytokines in the blood of patients, cytokines that also predispose to depression" said Famela Ramos, Vice President of Business Development for the Company. "It may be that the recent increase in suicides and suicide attempts is related biologically to activities of the coronavirus. It will be interesting to examine whether QuadraMune™ may modify putative negative mental effects of the virus."
"An estimated 17.3 million adults in the United States had at least one major depressive episode. This number represented 7.1% of all U.S. adults" stated Timothy Dixon, President and CEO of the Company. "We believe the Mission of our Company is not just providing a return on investment to our shareholders, but also increasing the quality of life for Americans. We are extremely pleased to report this unexpected finding with significant potential implications to advancing non-toxic means of helping patients with this terrible condition."
1 QuadraMune(TM) for Prevention of COVID-19 - Full Text View - ClinicalTrials.gov
2 Therapeutic Solutions International Announces Positive Preclinical and Clinical Evaluation of Nutritional Supplement QuadraMune™, Designed to Protect Against COVID-19 | BioSpace
3 Ting et al. Role of Interleukin-6 in Depressive Disorder. Int J Mol Sci. 2020 Mar 22;21(6):2194.
4 O'Donovan et al. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety. 2013 Apr;30(4):307-14.
AI
